Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews
Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews
分析师对医疗控股公司Select Medical进行了4次评估,揭示了更多信息。
Throughout the last three months, 4 analysts have evaluated Select Medical Hldgs (NYSE:SEM), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中,有4位分析师对Select Medical Hldgs(纽约证券交易所代码:SEM)进行了评估,提供了从看涨到看跌的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级,展示了过去30天内不断变化的情绪,并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.5, a high estimate of $48.00, and a low estimate of $40.00. This upward trend is apparent, with the current average reflecting a 7.88% increase from the previous average price target of $41.25.
分析师评估的12个月目标股价揭示了进一步的见解,平均目标价为44.5美元,最高估计为48.00美元,低估值为40.00美元。这种上升趋势显而易见,当前的平均价格较之前的平均目标价41.25美元上涨了7.88%。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级:全面细分
The perception of Select Medical Hldgs...
通过分析师最...
登录免费看全文
登录/注册